Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers

Alimentary Pharmacology & Therapeutics
N ElnachefW D Chey

Abstract

Our understanding of the benefits and risks of aspirin non steroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 (COX-2) selective NSAIDs and gastro-protective agents (GPAs) continues to expand. To assess the perceptions and practices of US primary care physicians (PCPs) regarding the use of aspirin, NSAIDs, COX-2 selective NSAIDs and GPA. A 34-question survey was administered to 1000 US PCPs via the internet. Questions addressed issues involving aspirin, NSAIDs, COX-2 selective NSAIDs, and GPAs. Around 491 of 1000 PCPs had participated in a similar survey conducted in 2003. Eighty-five per cent of PCPs reported that >25% of their patients were taking aspirin for preventive reasons. Nineteen per cent performed a risk calculation when deciding whether to start aspirin for cardioprotection. Fifty-four per cent recommended a proton pump inhibitor (PPI) for a patient with a recently healed ulcer who required ongoing aspirin. Thirty-one per cent reported prescribing NSAIDs more often and 52% were more likely to recommend a GPA with an NSAID than in 2003. Although PCPs were less likely to recommend a COX-2 selective NSAID compared to 2003, only 41% felt that rofecoxib increased cardiovascular risk. One-third felt that celecoxi...Continue Reading

References

Apr 1, 1995·BMJ : British Medical Journal·J WeilP Wainwright
Jun 17, 1999·The New England Journal of Medicine·M M WolfeG Singh
Sep 28, 2000·The American Journal of Gastroenterology·H T SørensenJ H Olsen
Feb 13, 2001·The American Journal of Medicine·J Brun, R Jones
Dec 26, 2001·The New England Journal of Medicine·F Catella-LawsonG A FitzGerald
Jan 16, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Jun 28, 2002·The New England Journal of Medicine·Kam Chuen LaiJohn Wong
Jan 31, 2003·Gastroenterology·Loren LaineClaire Bombardier
Feb 25, 2003·Lancet·T M MacDonald, L Wei
May 10, 2003·Lancet·Jeptha P Curtis, Harlan M Krumholz
Oct 8, 2003·Current Pharmaceutical Design·Angel LanasJosep M Piqué
Sep 2, 2004·Alimentary Pharmacology & Therapeutics·J L GoldsteinK M Verburg
Oct 7, 2004·Current Medical Research and Opinion·Douglas J WatsonThomas J Simon
Feb 3, 2005·Annals of Internal Medicine·Stephen E KimmelBrian L Strom
Mar 23, 2005·Current Opinion in Pharmacology·Dairong WangGarret A Fitzgerald
Mar 9, 2006·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Salaheddin M MahmudArmen G Aprikian
Aug 1, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·UNKNOWN American Gastroenterological AssociationLee Simon
Sep 5, 2006·Alimentary Pharmacology & Therapeutics·L Laine
Nov 8, 2006·Gastroenterology·John A BaronUNKNOWN APPROVe Trial Investigators
May 10, 2007·JAMA : the Journal of the American Medical Association·Charles L CampbellSteven R Steinhubl
Feb 22, 2008·The American Journal of Gastroenterology·Neena S AbrahamWalter Smalley
Apr 2, 2008·Circulation·Scott D SolomonUNKNOWN Cross Trial Safety Assessment Group

❮ Previous
Next ❯

Citations

Dec 17, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Maria A BiancoUNKNOWN Gas.Pro. Italian Group
Aug 31, 2012·Pain Practice : the Official Journal of World Institute of Pain·Anwar Z ZeidanStephan A Schug
Feb 9, 2017·Free Radical Research·Rômulo Pillon BarcelosGuilherme Bresciani
Oct 24, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Julie M HughesRonald W Matheny
Mar 30, 2013·Journal of Applied Physiology·Maria L Urso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Jay L GoldsteinDenise T Kruzikas
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Angel Lanas
© 2022 Meta ULC. All rights reserved